Chargement en cours...
In vitro activity of BAY v 3522, a new cephalosporin for oral administration.
The activity of BAY v 3522 was tested against over 500 clinical bacterial isolates and compared with the activities of ampicillin, amoxicillin-clavulanate, cefaclor, cefixime, cefuroxime, cephalexin, and/or ciprofloxacin, erythromycin, and metronidazole. BAY v 3522 activity against staphylococci and...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
1990
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC171947/ https://ncbi.nlm.nih.gov/pubmed/2285305 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|